ஸ்டீவ் ஹூவர் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

MAKO Medical Forges Partnership with the CDC North Carolina lab to provide nationwide next-generation sequencing of COVID-19 samples for identification of mutations and variants May 13, 2021 13:58 ET | Source: MAKO Medical MAKO Medical Raleigh, North Carolina, UNITED STATES Raleigh, North Carolina, May 13, 2021 (GLOBE NEWSWIRE) MAKO Medical Laboratories, a national reference laboratory and leader in COVID-19 testing, today announced a comprehensive partnership with the Centers for Disease Control and Prevention (CDC) to provide next-generation sequencing of SARS-CoV-2. Since January 2021, MAKO has utilized sequencing processes to analyze a group of more than 2,500 samples from tests conducted across its forty-three state testing footprint. To date, these efforts have identified the occurrence of multiple variants of the SARS-CoV-2 virus, including the B.1.1.7, B.1.351, and B.1.429 variants, across 25 states.

South africaUnited statesNorth carolinaUnited kingdomVance countySouth africanMark stevensonAmpliseq sars coBiosystems taqpathJosh arantThom tillisSteve hooverCenters for diseaseLaboratory operationsCollege of american pathologistsLife sciences award